Title: Director, The Preston Robert Tisch Brain Tumor Center at Duke
Institution: Duke University
Research: Focus on oncolytic poliovirus, immunotoxin, and checkpoint inhibitor therapy of gliomas. Intended outcome will represent paradigm shifts in glioblastoma multiforme cells (GBM) treatment resulting in significant increases in high quality of life and overall survival.
